These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 26549283)
1. Dramatic Response to Cardiac Resynchronization Therapy With AV Delay Optimization in Narrow QRS Heart Failure. Kogawa R; Nakai T; Ikeya Y; Mano H; Sonoda K; Sasaki N; Iso K; Okumura Y; Ohkubo K; Kunimoto S; Watanabe I; Hirayama A Int Heart J; 2015; 56(6):671-5. PubMed ID: 26549283 [TBL] [Abstract][Full Text] [Related]
2. Whether noninvasive optimization of AV and VV delays improves the response to cardiac resynchronization therapy. Urbanek B; Chudzik M; Klimczak A; Rosiak M; Lewek J; Wranicz JK Cardiol J; 2013; 20(4):411-7. PubMed ID: 23913460 [TBL] [Abstract][Full Text] [Related]
3. Three-dimensional echocardiographic optimization improves outcome in cardiac resynchronization therapy compared to ECG optimization: a randomized comparison. Sonne C; Bott-Flugel L; Hauck S; Hadamitzky M; Lesevic H; Demetz G; Braun D; Wolf P; Hausleiter J; Schömig A; Kolb C Pacing Clin Electrophysiol; 2014 Mar; 37(3):312-20. PubMed ID: 24164640 [TBL] [Abstract][Full Text] [Related]
4. Cardiac-resynchronization therapy in heart failure with a narrow QRS complex. Ruschitzka F; Abraham WT; Singh JP; Bax JJ; Borer JS; Brugada J; Dickstein K; Ford I; Gorcsan J; Gras D; Krum H; Sogaard P; Holzmeister J; N Engl J Med; 2013 Oct; 369(15):1395-405. PubMed ID: 23998714 [TBL] [Abstract][Full Text] [Related]
5. Is mechanical dyssynchrony a therapeutic target in heart failure with preserved ejection fraction? Menet A; Greffe L; Ennezat PV; Delelis F; Guyomar Y; Castel AL; Guiot A; Graux P; Tribouilloy C; Marechaux S Am Heart J; 2014 Dec; 168(6):909-16.e1. PubMed ID: 25458655 [TBL] [Abstract][Full Text] [Related]
6. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study. Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C; Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006 [TBL] [Abstract][Full Text] [Related]
7. Cardiac resynchronization therapy beyond nominal settings: who needs individual programming of the atrioventricular and interventricular delay? Bogaard MD; Meine M; Tuinenburg AE; Maskara B; Loh P; Doevendans PA Europace; 2012 Dec; 14(12):1746-53. PubMed ID: 22753868 [TBL] [Abstract][Full Text] [Related]
8. Fusion-optimized intervals (FOI): a new method to achieve the narrowest QRS for optimization of the AV and VV intervals in patients undergoing cardiac resynchronization therapy. Arbelo E; Tolosana JM; Trucco E; Penela D; Borràs R; Doltra A; Andreu D; Aceña M; Berruezo A; Sitges M; Mansour F; Castel A; Matas M; Brugada J; Mont L J Cardiovasc Electrophysiol; 2014 Mar; 25(3):283-92. PubMed ID: 24237881 [TBL] [Abstract][Full Text] [Related]
9. A randomized pilot study of optimization of cardiac resynchronization therapy in sinus rhythm patients using a peak endocardial acceleration sensor vs. standard methods. Ritter P; Delnoy PP; Padeletti L; Lunati M; Naegele H; Borri-Brunetto A; Silvestre J Europace; 2012 Sep; 14(9):1324-33. PubMed ID: 22549295 [TBL] [Abstract][Full Text] [Related]
10. Effects of AV delay and VV delay on left atrial pressure and waveform in ambulant heart failure patients: insights into CRT optimization. Chan WY; Blomqvist A; Melton IC; Norén K; Crozier IG; Benser ME; Eigler NL; Gutfinger D; Troughton RW Pacing Clin Electrophysiol; 2014 Jul; 37(7):810-9. PubMed ID: 24502608 [TBL] [Abstract][Full Text] [Related]
11. Relationship between QRS duration and left ventricular dyssynchrony in patients with end-stage heart failure. Bleeker GB; Schalij MJ; Molhoek SG; Verwey HF; Holman ER; Boersma E; Steendijk P; Van Der Wall EE; Bax JJ J Cardiovasc Electrophysiol; 2004 May; 15(5):544-9. PubMed ID: 15149423 [TBL] [Abstract][Full Text] [Related]
12. Impact of QRS morphology and duration on outcomes after cardiac resynchronization therapy: Results from the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial (RAFT). Birnie DH; Ha A; Higginson L; Sidhu K; Green M; Philippon F; Thibault B; Wells G; Tang A Circ Heart Fail; 2013 Nov; 6(6):1190-8. PubMed ID: 23995437 [TBL] [Abstract][Full Text] [Related]
13. [Electrocardiographic predictors of response to cardiac resynchronization therapy of heart failure in patients with dilated cardiomyopathy]. Vaĭkhanskaia TG; Kurushko TV; Sidorenko IV; Koptiukh TM; Gul' LM; Mel'nikova OP; Golenishcha VF; Kovalenko ON Kardiologiia; 2013; 53(3):48-54. PubMed ID: 23548427 [TBL] [Abstract][Full Text] [Related]
14. The clinical benefit of cardiac resynchronization therapy optimization using a device-based hemodynamic sensor in a patient with dilated cardiomyopathy: a case report. Volpicelli M; Covino G; Capogrosso P J Med Case Rep; 2015 Dec; 9():289. PubMed ID: 26683613 [TBL] [Abstract][Full Text] [Related]